Clinical study investigating the pharmacokinetics and bioavailability of oral hydroxyprogesterone [LPCN 1107] vs intramuscular hydroxyprogesterone in pregnant women

Trial Profile

Clinical study investigating the pharmacokinetics and bioavailability of oral hydroxyprogesterone [LPCN 1107] vs intramuscular hydroxyprogesterone in pregnant women

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jan 2015

At a glance

  • Drugs Hydroxyprogesterone (Primary) ; Hydroxyprogesterone
  • Indications Preterm labour
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 08 Sep 2014 Topline results expected in 2015, according to a Lipocine media release.
    • 08 Sep 2014 First patient dosed, according to a Lipocine media release.
    • 08 Sep 2014 Status changed from planning to recruiting, as reported in a Lipocine media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top